Towards Healthcare
Precision Oncology Market
Updated Date: 19 December 2025   |   Report Code: 5054
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Precision Oncology Market Developments Shaping Future Care

The precision oncology market size is calculated at $132.87 billion in 2025 is to hit $341.51 billion by 2035. COTA, Inc. and Guardant Health collaborated to advance biomarker-based cancer therapies. Caris Life Sciences added UVA Cancer Center to its Precision Oncology Alliance. Scorpion Therapeutics raised $150M for STX-478. NIH launched myeloMATCH trials, and LabCorp expanded precision oncology with Plasma Detect.

Last Updated : 19 December 2025 Category: Therapeutic Area Insight Code: 5054 Format: PDF / PPT / Excel

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Precision Oncology Market Assessment

  • Overview
  • Global Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Global Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Global Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies
  • Global Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa

North America Precision Oncology Market Assessment

  • Overview
  • North America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • North America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • North America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Europe Precision Oncology Market Assessment

  • Overview
  • Europe Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Europe Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Europe Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Asia-Pacific Precision Oncology Market Assessment

  • Overview
  • Asia-Pacific Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Asia-Pacific Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Asia-Pacific Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Latin America Precision Oncology Market Assessment

  • Overview
  • Latin America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Latin America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Latin America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Middle East and Africa Precision Oncology Market Assessment

  • Overview
  • Middle East and Africa Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Middle East and Africa Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Middle East and Africa Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Company Profiles

  • Thermo Fisher Scientific, Inc. 
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Invitae Corporation
  • Illumina, Inc.
  • Myriad Genetics, Inc
  • AstraZeneca
  • Rain Oncology Inc.
  • Strata Oncology, Inc.
  • Repare Therapeutics
  • Relay Therapeutics
  • Exscientia
  • Exact Sciences Corporation

Conclusion & Recommendations

FAQ's

Answer : The global precision oncology market is projected to grow from USD 132.87 billion in 2025 to USD 341.51 billion by 2035 at a CAGR of 9.9%, driven by rising cancer prevalence and personalized medicine demand.

Answer : North America, particularly the U.S., leads precision oncology due to advanced research and regulatory support, while Asia Pacific emerges as the fastest-growing region fueled by rising cancer burden and government initiatives.

Answer : American Cancer Society Inc, National Library of Medicine, and World Health Organization
Any Questions

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar
WhatsApp